Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Símbolo de cotizaciónINBS
Nombre de la empresaIntelligent Bio Solutions Inc
Fecha de salida a bolsaDec 23, 2020
Director ejecutivoMr. Harry Simeonidis
Número de empleados13
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 23
Dirección135 W 41St St,
CiudadNEW YORK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal10036
Teléfono16467905756
Sitio Webhttps://ibs.inc/
Símbolo de cotizaciónINBS
Fecha de salida a bolsaDec 23, 2020
Director ejecutivoMr. Harry Simeonidis
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos